Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dihydrolipoamide S-succinyltransferase pseudogene 1 (DLSTP1) is a human pseudogene with sequence similarity to the functional gene dihydrolipoamide S-succinyltransferase (DLST), a component of the 2-oxoglutarate dehydrogenase complex in mitochondria, but DLSTP1 itself does not encode a functional protein or enzyme. Pseudogenes such as DLSTP1 typically result from gene duplication, retrotransposition, or disabling mutations, and are generally nonfunctional; some pseudogenes can regulate gene expression by serving as microRNA sponges or competitive endogenous RNAs, but there is no specific evidence that DLSTP1 has such functions. It is not considered a therapeutic target. DLSTP1 should not be confused with functional targets, and it is not a receptor, enzyme, transporter, or other classical drug target. If the intent was to query a therapeutic target, this is likely an error.
None (as above, not targeted by drugs)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dihydrolipoamide S-succinyltransferase pseudogene 1 (DLSTP1).